We evaluated serum levels of S100B and neuron-specific enolase (NSE) in 54 mild, moderate and severe Alzheimer's disease (AD) patients and in 66 community-dwelling elderly. Here, S100B is linked to early-onset autosomal dominant Alzheimer disease.